Correlation Between Eliem Therapeutics and ATyr Pharma
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and ATyr Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and ATyr Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and ATyr Pharma, you can compare the effects of market volatilities on Eliem Therapeutics and ATyr Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of ATyr Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and ATyr Pharma.
Diversification Opportunities for Eliem Therapeutics and ATyr Pharma
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Eliem and ATyr is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and ATyr Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ATyr Pharma and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with ATyr Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ATyr Pharma has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and ATyr Pharma go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and ATyr Pharma
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 1.04 times more return on investment than ATyr Pharma. However, Eliem Therapeutics is 1.04 times more volatile than ATyr Pharma. It trades about 0.04 of its potential returns per unit of risk. ATyr Pharma is currently generating about -0.04 per unit of risk. If you would invest 259.00 in Eliem Therapeutics on September 14, 2024 and sell it today you would earn a total of 50.00 from holding Eliem Therapeutics or generate 19.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 74.85% |
| Values | Daily Returns |
Eliem Therapeutics vs. ATyr Pharma
Performance |
| Timeline |
| Eliem Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| ATyr Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Eliem Therapeutics and ATyr Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and ATyr Pharma
The main advantage of trading using opposite Eliem Therapeutics and ATyr Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, ATyr Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATyr Pharma will offset losses from the drop in ATyr Pharma's long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| ATyr Pharma vs. Mereo BioPharma Group | ATyr Pharma vs. Terns Pharmaceuticals | ATyr Pharma vs. PDS Biotechnology Corp | ATyr Pharma vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |